Research Compound Profile

Cagrilintide (AM833): Research Profile (November 2026)

Cagrilintide is a long-acting acylated analogue of human amylin that agonizes both amylin and calcitonin receptors. It exists because native amylin aggregates into fibrils too readily to be useful as a long-acting agent.

For laboratory research and educational purposes only. This profile summarizes published preclinical and analytical literature and is not medical advice or dosing guidance.

Research-Grade Cagrilintide

Supplied as Cagrilintide + Semaglutide with a batch-specific HPLC and mass spectrometry COA — verify any batch.

Further Reading

Other Compound Profiles